Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

228976

registered interest
date	23/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what will be the position of patients, previously served by a dispensing doctor practice, who live within 1.6 km of a pharmacy that closes, but still retains its licence, as a result of the closure of the Essential Small Pharmacies Scheme on 1 April 2015.
tabling member printed	The Countess of Mar
uin	HL5941
answer	answer is ministerial correction date of answer 25/03/2015 answer text <p>The ending of the essential small pharmacy local pharmaceutical services scheme on 31 March 2015 does not require such pharmacies to close. That is a decision for the individual contractor concerned. They may decide to return to the main National Health Service pharmaceutical list and come under the terms of the national community pharmacy contractual framework. Alternatively, they can decide to submit a proposal to NHS England to provide local pharmaceutical services. NHS England is working with individual providers of essential small pharmacies to ensure people in affected communities can continue to access appropriate NHS pharmaceutical services. However, if an essential small pharmacy – or any other type of pharmacy - did decide to close, it would no longer be able to provide NHS pharmaceutical services.</p><p> </p><p> </p><p> </p><p>Patients can at any time request in writing that a doctor provides them with NHS pharmaceutical services. Applications should be made via the doctor to the appropriate NHS England office. To be eligible to receive dispensing services from a doctor, a patient must meet certain criteria, such as having serious difficulty obtaining services from a pharmacy or the patient lives in a designated rural area, more than 1.6 kilometres from the nearest pharmacy. These criteria are set out in Regulation 48 of the National Health Services (Pharmaceutical Services and Local Pharmaceutical Services) Regulations 2013 – SI 2013/349. A patient must also be on the doctor’s patient list, or the patient list of the practice at which the doctor provides or performs primary medical services, and the practice must be authorised by NHS England to provide NHS dispensing services.</p><p> </p> answering member printed Earl Howe question first answered 25/03/2015 16:21:09 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

226833

registered interest
date	11/03/2015
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aircraft: Air Conditioning
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Transport, Robert Goodwill, on 4 March (HC225506), how many fume events occurred in flights observed by researchers conducting the Cranfield University study; whether the available health and safety standards and guidelines include the effects of pyrolised oil at temperatures exceeding 400 degrees Celsius in an enclosed space; and what assessment they have made of the advice from the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment that contaminated air is causing ill health but that they do not know the mechanism by which it has that effect.
tabling member printed	The Countess of Mar
uin	HL5627
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>A total of 38 flights had fumes or smells reported by at least one crew member or researcher during the Cranfield study. The Health and Safety Executive are responsible for introducing guidelines on health and safety at work legislation. However, the Cranfield study found that with respect to the conditions of flight that were experienced during the cabin air sampling, there was no evidence for pollutants occurring in cabin air at levels exceeding available health and safety standards and guidelines. The Committee on Toxicity (the COT) made a number of conclusions in their assessment. The Department welcomed these and forwarded the COT report to the European Aviation Safety Agency for their information.</p> answering member printed Baroness Kramer question first answered 17/03/2015 12:53:30 answering member 1557 label Biography information for Baroness Kramer
tabling member	1861 label Biography information for The Countess of Mar

226479

registered interest
date	10/03/2015
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aircraft: Air Conditioning
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under Secretary of State for Transport, Robert Goodwill, on 5 March (HC225928), what evidence is currently being reviewed by the Civil Aviation Authority in respect of the possibility of genetic factors which might influence individual susceptibility to environmental toxins.
tabling member printed	The Countess of Mar
uin	HL5601
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>The Civil Aviation Authority are reviewing the issue of genetic susceptibility to toxins in the context of documents provided by Dorset Coroner’s office.</p> answering member printed Baroness Kramer question first answered 17/03/2015 12:52:56 answering member 1557 label Biography information for Baroness Kramer
tabling member	1861 label Biography information for The Countess of Mar

224224

registered interest
date	27/02/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Employment and Support Allowance
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the written statement by Lord Freud on 27 November 2014 (HLWS32), when they plan to bring forward the measure to prevent claimants being paid the Employment Support Allowance assessment rate if they have already been found fit for work but have made a repeat claim, and what consideration they have given to the implications this will have for disabled people and those with fluctuating conditions.
tabling member printed	The Countess of Mar
uin	HL5277
answer	answer is ministerial correction date of answer 11/03/2015 answer text <p /> <p>The Regulations that implement the measure making changes to how repeat claims for Employment and Support Allowance are dealt with were laid before Parliament on 5th March.</p><p> </p><p>The Regulations can be found at <a href="http://www.legislation.gov.uk/id/uksi/2015/437" target="_blank">http://www.legislation.gov.uk/id/uksi/2015/437</a>.</p><p> </p><p>The criteria for eligibility for the support group in Employment and Support Allowance remains the same for men and women.</p><p> </p><p>The updated guidance for healthcare professionals on the assessment of risk in claimants with a Mental Health condition was developed with input from senior psychiatrists. It differentiates between men and women in relation to suicide risk because the suicide rate in men is significantly higher than in women.</p><p> </p><p>The guidance makes clear that the assessment of risk needs to focus both on the claimant’s health and whether the claimant could cope with work-related activity.</p> answering member printed Lord Freud grouped question UIN HL5278 question first answered 11/03/2015 16:49:33 answering member 3893 label Biography information for Lord Freud
tabling member	1861 label Biography information for The Countess of Mar

224225

registered interest
date	27/02/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Work Capability Assessment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the scoring for Work Capability Assessment applicants with mental health problems has been loaded to make it more difficult for women to qualify for the support group than it is for men; and, if so, why.
tabling member printed	The Countess of Mar
uin	HL5278
answer	answer is ministerial correction date of answer 11/03/2015 answer text <p>The Regulations that implement the measure making changes to how repeat claims for Employment and Support Allowance are dealt with were laid before Parliament on 5th March.</p><p> </p><p>The Regulations can be found at <a href="http://www.legislation.gov.uk/id/uksi/2015/437" target="_blank">http://www.legislation.gov.uk/id/uksi/2015/437</a>.</p><p> </p><p>The criteria for eligibility for the support group in Employment and Support Allowance remains the same for men and women.</p><p> </p><p>The updated guidance for healthcare professionals on the assessment of risk in claimants with a Mental Health condition was developed with input from senior psychiatrists. It differentiates between men and women in relation to suicide risk because the suicide rate in men is significantly higher than in women.</p><p> </p><p>The guidance makes clear that the assessment of risk needs to focus both on the claimant’s health and whether the claimant could cope with work-related activity.</p> answering member printed Lord Freud grouped question UIN HL5277 question first answered 11/03/2015 16:49:33 answering member 3893 label Biography information for Lord Freud
tabling member	1861 label Biography information for The Countess of Mar

167280

registered interest
date	02/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many adverse reactions to Cervarix, Gardasil and unbranded human papilloma virus vaccines have been reported to the Medicines and Healthcare Products Regulatory Agency up to the most recent date; how many of those reports are of serious adverse reactions for each category; and what is the age specific rate that these figures represent.
tabling member printed	The Countess of Mar
uin	HL3381
answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>A total of 7947 suspected adverse reaction reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare Products Regulatory Agency (MHRA) via the Yellow Card Scheme up to 3 December 2014. It is important to note that a Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine may have been the cause. The frequency of known side effects is listed in the product information (the Summary of Product Characteristics for health professionals and the Patient Information Leaflet) which are provided with the vaccines.</p><p> </p><p> </p><p> </p><p>The following table provides a breakdown of these reports by brand and seriousness.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Vaccine Brand</p></td><td><p>Total number of reports</p></td><td><p>Number of serious reports (% of total)</p></td></tr><tr><td><p>Cervarix</p></td><td><p>6,260</p></td><td><p>1,762 (28%)</p></td></tr><tr><td><p>Gardasil</p></td><td><p>1,200</p></td><td><p>459 (38%)</p></td></tr><tr><td><p>HPV Brand unspecified</p></td><td><p>488</p></td><td><p>308 (63%)</p></td></tr><tr><td><p>Total</p></td><td><p>7,948*</p></td><td><p>2529 (32%)</p></td></tr></tbody></table><p> </p><p><em>Note:</em></p><p> </p><p>*The total number of reports received will not equal the total in the table above as some reports may have more than one suspect vaccine.</p><p> </p><p> </p><p> </p><p>The MHRA does not hold data on age-specific usage therefore we are unable to provide the age-specific rate that these figures represent. The MHRA continually reviews safety of the vaccine and, following administration of over 7 million doses in the UK alone, no serious new risks have been identified. The benefits in protecting against HPV-related disease far outweigh any possible side effects of the vaccine.</p><p> </p> answering member printed Earl Howe question first answered 16/12/2014 15:34:13 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

166877

registered interest
date	01/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Records
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether clinical commissioning groups, general practitioner surgeries or any other National Health Service bodies have the legal right to provide insurance companies, or anyone else outside the National Health Service, with patients’ details, including their medical details; if so, which legislation permits such action; and, if any payment is received for supplying such information, to whom it is made.
tabling member printed	The Countess of Mar
uin	HL3295
answer	answer is ministerial correction date of answer 05/12/2014 answer text <p>In the vast majority of cases National Health Service organisations may only provide confidential information about a patient to insurance companies and other third parties such as employers with the explicit consent of the patient. However, there may be a small number of cases where disclosure may take place without seeking consent, for example where there is a court order. Healthcare professionals who supply medical reports to insurance companies and employers may charge a fee for doing so; NHS organisations that supply copies of medical records may charge a fee that covers their costs.</p><p> </p> answering member printed Earl Howe question first answered 05/12/2014 14:32:42 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

156575

registered interest
date	19/11/2014
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Employment and Support Allowance
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many claimants for Employment Support Allowance who have degenerative conditions for which there is no possibility of improvement have been placed in the Work-Related Activity Group; how many have found employment; how many have had their benefits reduced for failing to find employment; whether the position of those claimants will be reviewed; and, if so, when.
tabling member printed	The Countess of Mar
uin	HL2998
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p /> <p>The information as requested is not available.</p> answering member printed Lord Freud question first answered 27/11/2014 12:30:03 answering member 3893 label Biography information for Lord Freud
tabling member	1861 label Biography information for The Countess of Mar

156576

registered interest
date	19/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government which organisations within the National Health Service or which represent members who provide services to the National Health Service are bound by the World Health Organisation’s International Classification of Diseases (ICD—10).
tabling member printed	The Countess of Mar
uin	HL2999
answer	answer is ministerial correction date of answer 26/11/2014 answer text <p>The United Kingdom as a member state of the World Health Organization (WHO) is expected to comply with the WHO Nomenclature Regulations 1967 and is required to use the most current version of the International Classification of Diseases (ICD-10) for reporting cause of death and disease for compiling and publishing mortality and morbidity statistics. As such all providers of National Health Service funded care are required to submit ICD-10 codes for national reporting.</p><p> </p> answering member printed Earl Howe question first answered 26/11/2014 12:58:45 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

156577

registered interest
date	19/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government why they do not record the numbers of people who are diagnosed with chronic fatigue syndrome/myalgic encephalomyelitis, given that current estimates are based on extrapolations from other countries.
tabling member printed	The Countess of Mar
uin	HL3000
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>With the exception of cancer, there is no comprehensive central record of disease diagnosis for any condition. In 2007, the National Institute for Health and Care Excellence produced the clinical guidance, <em>Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children</em> which estimates that the annual prevalence is approximately 4000 cases per million of the population.</p><p> </p> answering member printed Earl Howe question first answered 27/11/2014 12:42:01 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar